Global Newswire by Notified: M&A

AUGUST 15, 2024

Protect Pharmaceutical Corp. PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger.

Pharmaceutical 85

Pharmaceutical Mergers 85

PE Hub

JANUARY 17, 2024

The post PE-backed Alcami acquires Pacific Pharmaceutical Services appeared first on PE Hub. Alcami is a contract development and manufacturing organization.

Pharmaceutical 76

Pharmaceutical Manufacturing 76

Global Banking & Finance

AUGUST 7, 2024

July 2024 – The pharmaceutical industry is making remarkable progress in its quest for decarbonisation, with emissions already on a significant decline. Yet, the journey to Net Zero remains fraught with challenges, particularly in curbing Scope 3 emissions within the workplace.

Pharmaceutical 52

Pharmaceutical IT Business 52

Global Newswire by Notified: M&A

MARCH 20, 2024

Nika Pharmaceuticals, Inc. OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.

Pharmaceutical 89

Pharmaceutical Mergers IT 89

PE Hub

JANUARY 3, 2024

The post Avista-backed Cosette Pharmaceuticals acquires women’s sexual health brand Vyleesi appeared first on PE Hub. The seller was Palatin Technologies Inc.

Pharmaceutical 84

Pharmaceutical 84

Global Newswire by Notified: M&A

AUGUST 19, 2024

19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. NEW YORK, Aug. NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and Contribution and Share Exchange Agreement (the “Merger Agreement”) regarding a business combination with KE Sdn. The Merger Agreement was approved by Titan’s board of directors (the “Board”).

Pharmaceutical 53

Pharmaceutical Mergers Shares Business 53

Global Newswire by Notified: M&A

JULY 28, 2023

Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3

Pharmaceutical 76

Pharmaceutical Shares 76

Global Newswire by Notified: M&A

JULY 24, 2024

Westford,USA, July 24, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Pharmaceutical Packaging Market will attain a value of USD 301.23 These include designing, distributing and manufacturing packaging materials to help meet the unique needs of the pharmaceutical packaging industry. billion by 2031, with a CAGR of 9.9%

Pharmaceutical 40

Pharmaceutical Healthcare Manufacturing 40

Global Newswire by Notified: M&A

JUNE 9, 2024

Selechimica”), an Italian distributor in the pharmaceutical industry. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L.

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

PE Hub

SEPTEMBER 22, 2023

The post Gurnet Point and Novo Holdings complete take-private buyout of Paratek Pharmaceuticals appeared first on PE Hub. The purchase price is about $462 million.

Pharmaceutical 79

Pharmaceutical 79

Global Newswire by Notified: M&A

JULY 1, 2024

Protect Pharmaceutical Corp. Issues Corporate Update.

Pharmaceutical 49

Pharmaceutical Corporation 49

JD Supra: Mergers

SEPTEMBER 4, 2024

August 01, 2024: SEAM Group, a B2B business products and services company that provides safety, reliability, maintenance, and enterprise asset management services in the hospitality, food processing, and pharmaceutical industries, was acquired by ABB for an undisclosed amount.

M&A 167

M&A Hospitality Asset Management Pharmaceutical 167

Global Newswire by Notified: M&A

APRIL 23, 2024

a European distributor in the pharmaceutical and nutraceutical industry. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Spain has signed an agreement to acquire 100% of the shares in Cobapharma, S.L.U,

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

Global Newswire by Notified: M&A

MARCH 21, 2024

March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. DEER PARK, Ill.,

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

PE Hub

JUNE 6, 2023

The post Gurnet Point and Novo Holdings to acquire Paratek Pharmaceuticals for $462m appeared first on PE Hub. Oaktree Capital Management will provide $175 million in debt financing for this deal.

Pharmaceutical 74

Pharmaceutical Debt Finance Finance 74

Global Newswire by Notified: M&A

JUNE 12, 2024

Westford USA, June 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Active Pharmaceutical Ingredients Market will attain a value of USD 351.81 Furthermore, the changing consumer taste towards personalized and precision medicine is expected to drive the active pharmaceutical ingredient (API) market. Billion by 2031, with a CAGR of 5.9%

Pharmaceutical 40

Pharmaceutical 40

PE Hub

NOVEMBER 14, 2023

The post Nordic Capital bets it can help the pharmaceutical industry speed up technology adoption appeared first on PE Hub. Nordic is acquiring the majority stake in IntegriChain, a Philadelphia-based provider of technology for the life sciences industry, from Accel-KKR.

Pharmaceutical 65

Pharmaceutical Capital IT 65

Global Newswire by Notified: M&A

DECEMBER 4, 2023

Rising demand for functional excipients and oral pharmaceutical medicines and increasing number of pharmaceuticals industries across the globe are key factors driving Pharmaceutical Excipients market revenue growth.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

JANUARY 4, 2024

Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (API) market revenue growth Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (..)

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

AUGUST 3, 2023

SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 billion by 2030, with a CAGR of 6.9% over the forecast period (2023-2030).

Pharmaceutical 40

Pharmaceutical Manufacturing 40

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

JD Supra: Mergers

JULY 10, 2024

Cephalon, Inc., 2018-0075-SG (Del. 30, 2024) - Stockholder representatives of an acquired corporation brought claims alleging that defendants had failed to use contractually-required commercially reasonable efforts to commercialize an acquired drug asset for a particular use. By: Morris James LLP

Pharmaceutical 161

Pharmaceutical Mergers Corporation 161

Global Newswire by Notified: M&A

MARCH 11, 2024

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. Nasdaq: CDT ) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation.

Pharmaceutical 45

Pharmaceutical Portfolio Acquisitions 45

Global Newswire by Notified: M&A

JANUARY 2, 2024

The global Pharmaceutical Packaging market size is expected to reach USD 249.41 Additionally, the rise in generic drug manufacturing, advancements in pharmaceutical technologies, and the push for sustainable and eco-friendly packaging options are also contributing factors fueling the market's growth.

Pharmaceutical 40

Pharmaceutical Healthcare Manufacturing 40

Global Newswire by Notified: M&A

JULY 31, 2024

Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of RSDL ® (Reactive Skin Decontamination Lotion) kit from Emergent BioSolutions Inc. NYSE: EBS) for an up-front payment of approximately $75 million.

Pharmaceutical 40

Pharmaceutical Acquisitions Medical Manufacturing 40

Global Banking & Finance

MARCH 5, 2024

Active Pharmaceutical Ingredients Market to hit $ 372.6 billion by 2030: Verified Market Reports The Global Active Pharmaceutical Ingredients Market size was valued at USD 237.3 Billion in 2023 and is expected to reach USD 372.6 Billion by the end of 2030 with a CAGR of 6.9% During the Forecast Period 2023-2030.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

JANUARY 31, 2024

The global Pharmaceutical Analytical Testing Outsourcing market size is expected to reach USD 15.09 The global Pharmaceutical Analytical Testing Outsourcing market size is expected to reach USD 15.09 billion by 2030 and exhibit a CAGR of 8.4% in the forecast period (2023−2030), according to Skyquest's latest research report.

Pharmaceutical 40

Pharmaceutical 40

JD Supra: Mergers

APRIL 18, 2024

On March 26, 2024, Skadden hosted a discussion on key developments in antitrust enforcement in the pharmaceuticals and life sciences sectors. By: Skadden, Arps, Slate, Meagher & Flom LLP

Pharmaceutical 172

Pharmaceutical 172

Global Newswire by Notified: M&A

MAY 6, 2024

Lophos", or the "Company") (CSE:MESC) is pleased to announce that its wholly-owned subsidiary, Lophos Pharmaceuticals Corp. NAPANEE, Ontario, May 06, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc.

Pharmaceutical 45

Pharmaceutical Sale Business IT 45

Global Newswire by Notified: M&A

APRIL 15, 2024

Nika Pharmaceuticals, Inc. NKPH) announces the purchase of technologies for production of three generic drugs in tablet form and one dietary supplement.

Pharmaceutical 45

Pharmaceutical 45

Global Newswire by Notified: M&A

SEPTEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., SAN DIEGO, Sept.

Pharmaceutical 40

Pharmaceutical Acquisitions Business 40

Global Newswire by Notified: M&A

JULY 2, 2024

July 02, 2024 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. PALO ALTO, Calif., a Cayman Islands corporation and special purpose acquisition company (Nasdaq: DECA, “SPAC”), today announced the signing of a letter of intent for a proposed business combination, which provides for a pre-transaction equity value of Semnur up to $2.0

Pharmaceutical 72

Pharmaceutical Acquisitions Capital Business 72

Global Newswire by Notified: M&A

JULY 13, 2023

West Conshohocken, PA, July 13, 2023 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today that it has acquired two life-saving medicines, Vistogard ® (uridine triacetate) and Xuriden ® (uridine triacetate), from Wellstat Therapeutics.

Pharmaceutical 40

Pharmaceutical IT 40

Global Newswire by Notified: M&A

AUGUST 4, 2023

SkyQuest projects that the pharmaceutical processing equipment market will attain a value of USD 15.71 The growth of the pharmaceutical processing equipment market can be attributed to several factors. SkyQuest projects that the pharmaceutical processing equipment market will attain a value of USD 15.71

Pharmaceutical 40

Pharmaceutical Manufacturing 40

Global Newswire by Notified: M&A

SEPTEMBER 4, 2024

Olon, the leading chemical-pharmaceutical group in the production and development of active pharmaceutical ingredients (APIs) and part of the holding company P&R, continues its growth path and announces a new venture: it will acquire HuvePharma Italia Srl and its site in Garessio, (Cuneo, Italy) with a significant increase in its total production (..)

Pharmaceutical 52

Pharmaceutical IT Acquisitions 52

Global Newswire by Notified: M&A

MAY 1, 2024

SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries.

Pharmaceutical 40

Pharmaceutical Shares Acquisitions 40